Although B cells produce cytokines it is not known whether B cells can differentiate into effector subsets that secrete polarized arrays of cytokines. We have identified two populations of "effector" B cells (Be1 and Be2) that produce distinct patterns of cytokines depending on the cytokine environment in which the cells were stimulated during their primary encounter with antigen and T cells. These effector B cell subsets subsequently regulate the differentiation of naïve CD4+ T cells to TH1 and TH2 cells through production of polarizing cytokines such as interleukin 4 and interferon gamma. In addition, Be1 and Be2 cells could be identified in animals that were infected with pathogens that preferentially induce a Type 1 and Type 2 immune response. Together these results suggest that, in addition to their well defined role in antibody production, B cells may regulate immune responses to infectious pathogens through their production of cytokines.
Summary Immunity to the intestinal parasite, Heligomosomoides polygyrus, is dependent on the successful generation of Th2 memory cells. We show that B cells contribute to immunity against H. polygyrus by producing antibody and by promoting expansion and differentiation of primary and memory Th2 cells. We also demonstrate that cytokine-producing “effector” B cells are essential for effective immunity to H. polygyrus. TNFα production by B cells is necessary for sustained Ab production, while IL-2 production by B cells is necessary for Th2 expansion and differentiation. These results show that B cells mediate protection to pathogens not only by presenting antigen and secreting antibody but also by producing cytokines that regulate the quality and magnitude of humoral and cellular immune responses.
This manuscript systematically identifies the molecular mechanisms that regulate the ability of B cells to produce the critical type 1 cytokine, IFN-γ. B cells produce IFN-γ in response to IL-12 and IL-18 and when primed by Th1 cells. We show that development of IFN-γ-producing B cells by either Th1 cells or IL-12/IL-18 is absolutely dependent on expression of the IFN-γR and the T-box transcription factor, T-bet. Interestingly, although T-bet up-regulation in developing B effector 1 (Be1) cells is controlled by IFN-γR-mediated signals, STAT1-deficient B cells up-regulate T-bet and produce IFN-γ, indicating that additional transcriptional activators must be coupled to the IFN-γR in B cells. Finally, we show that although IL-12/IL-18 or IFN-γ-producing Th1 cells are required to initiate transcription of the IFN-γ gene in B cells, sustained expression of IFN-γ and T-bet by B cells is dependent on an IFN-γ/IFN-γR/T-bet autocrine feedback loop. These findings have significant implications, because they suggest that IFN-γ-producing B cells not only amplify Th1 responses, but also imprint a type 1 phenotype on B cells themselves. In the case of immune responses to bacterial or viral pathogens, this B cell-driven autocrine feedback loop is likely to be beneficial; however, in the case of B cell responses to autoantigens, it may result in amplification of the autoimmune loop and increased pathology.
The basic helix-loop-helix protein, E2A, is required for proper early B lymphopoiesis. Specifically, in E2A-deficient mice, B-cell development is blocked at the progenitor stage prior to the onset of immunoglobulin (Ig) V(D)J recombination. Here, we demonstrate that E2A plays an additional role during peripheral B lymphopoiesis. Upon activation of primary mature B lymphocytes, both E2A protein levels and DNAbinding activity are induced. Furthermore, we show that mature B cells, expressing a dominant-negative E2A antagonist, proliferate normally in response to mitogenic signaling and appropriately express the early and late activation markers CD69, CD44, IgD and B220. However, in the absence of E2A activity, B lymphocytes are blocked in their ability to express secondary Ig isotypes. We demonstrate that the defect lies at the level of DNA rearrangements between the Ig switch regions. These data suggest that E2A is an essential target during B-cell activation and its induction is required to promote Ig class switch recombination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.